National Coverage Analysis of Outpatient Intravenous Insulin Therapy
Medicare often makes National Coverage Determinations which set forth the extent to which Medicare will cover specific services, procedures, or technologies on a national basis. Medicare has begun making such a determination for MAT®Treatment (Metabolic Activation Therapy), under the broader class of therapies it terms “outpatient intravenous insulin therapy”.
The Coverage Determination process starts with a National Coverage Analysis. TheTracking Sheet describes the National Coverage Analysis for this therapy –